iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Astrazeneca Pharma India standalone net profit declines 45.75% in the December 2021 quarter

9 Feb 2022 , 08:13 AM

Net profit of Astrazeneca Pharma India declined 45.75% to Rs 11.42 crore in the quarter ended December 2021 as against Rs 21.05 crore during the previous quarter ended December 2020. Sales rose 0.14% to Rs 200.53 crore in the quarter ended December 2021 as against Rs 200.25 crore during the previous quarter ended December 2020.

Particulars Quarter Ended
? Dec. 2021 Dec. 2020 % Var.
Sales 200.53 200.25 0
OPM % 7.32 15.35
PBDT 19.78 33.41 -41
PBT 16.27 28.30 -43
NP 11.42 21.05 -46

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.